AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2021
Jul 2, 2021
30870_dirs_2021-07-02_f76b0c33-00fd-4b8d-9474-29b957d5bf94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-07-01
Reporting Person: Kaye Edward M. MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Common Stock | A | 476 | $20.98 | Acquired | 6396 | Direct |
Footnotes
F1: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $20.98, representing the Issuer's closing stock price on July 1, 2021.
F2: Amount includes 1,396 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18